Eyenovia Inc.

NASDAQ: EYENHealthcare / Biotechnology / USA
3.19+0.0100+0.31%Vol 167 3501Y Perf -51.29%
Jul 19th, 2019 16:00
BID3.14 ASK3.26
Open3.15 Previous Close3.18
Pre-Market- After-Trading-
 - -%  - -%
Target Price
18.25 
Analyst Rating
Strong Buy 1.00
Potencial %
472.10 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)38 
Earnings Rating
Sell
Price Range Ratio 52wk %
17.25 
Earnings Date
13th Aug 2019

Today's Price Range

3.013.27

52wk Range

2.406.98

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
11.93%
1 Month
-30.35%
3 Months
-51.07%
6 Months
14.75%
1 Year
-51.29%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
EYEN3.190.01000.31
AAPL202.59-3.0700-1.49
GOOG1 130.10-16.2300-1.42
MSFT136.620.20000.15
XOM74.990.15000.20
WFC46.030.21000.46
JNJ130.31-1.7600-1.33
FB198.36-2.4200-1.21
GE10.04-0.0200-0.20
JPM113.54-1.1300-0.99
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.51-0.501.96
Q04 2018-0.43-0.60-39.53
Q03 2018-0.42-0.43-2.38
Q02 2018-0.39-0.3315.38
Q01 2018-0.39-0.45-15.38
Q04 2017-0.34-0.84-147.06
----
----
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.47-9.30Negative
9/2019 QR-0.420.00-
12/2019 FY-1.80-5.88Negative
12/2020 FY-1.54-1.99Negative
Next Report Date13th Aug 2019
Estimated EPS Next Report-0.47
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume167 350
Shares Outstanding (in ths.)12 054
Trades Count479
Dollar Volume473 237
Avg. Volume174 137
Avg. Weekly Volume297 869
Avg. Monthly Volume228 707
Avg. Quarterly Volume104 644
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Eyenovia Inc.

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

CEO: Tsontcho Ianchulev

Teplephone: +1 917 289-1117

Address: 295 Madison Avenue, New York 10017, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

38%63%

Bearish Bullish

38%63%

News